The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma

Osteosarcoma is a highly aggressive malignancy for which treatment has remained essentially unchanged for years. Our previous studies found that the F-box protein SKP2 is overexpressed in osteosarcoma, acting as a proto-oncogene; p27Kip1 (p27) is an inhibitor of cyclin-dependent kinases and a downst...

Full description

Bibliographic Details
Main Authors: Aldahamsheh, O. (Author), Borjihan, H. (Author), Ferrena, A. (Author), Geller, D.S (Author), Gorlick, R. (Author), Hoang, B.H (Author), Lo, Y. (Author), Schwartz, E.L (Author), Singh, S. (Author), Singla, A. (Author), Tingling, J. (Author), Viscarret, V. (Author), Wang, J. (Author), Yaguare, S. (Author), Yang, R. (Author), Zhao, H. (Author), Zheng, D. (Author), Zi, X. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
p27
Online Access:View Fulltext in Publisher